Teiko Platform

What we're building

Platform

Commentable gating

72-hour comment window for gate adjustments, with email notifications and rollback support.

Now
Q2 2026

Platform

Gating page redesign

Rebuilt gating view with improved layout and faster load across large panels.

Now
Q2 2026

Platform

Self-service admin

Domain-based team invites so sponsors can add users without contacting Teiko.

Now
Q2 2026

Platform

TokuCompute

Import your own cytometry dataset for analysis. Currently in alpha with select sponsors.

Now
Q2 2026

Platform

Instant dashboard access at kickoff

Dashboard provisioned at work order signature, with verification reports and gating scheme pre-loaded.

Now
Q2 2026

Platform

Assay variability overlay

CV bands shown on immune changes plots to distinguish noise from a true drug effect.

Next
Q3 2026

Platform

Add your own metadata

Incorporate sponsor-provided metadata columns (e.g., responder status, dose group) directly in the dashboard.

Next
Q3 2026

Platform

Baseline normalization for population statistics

Compare treatment timepoints against each subject's own baseline, not just across cohorts.

Next
Q3 2026

Platform

Panel verification report in dashboard

Gating scheme and verification data accessible alongside study data from day one.

Next
Q3 2026

Lab Operations

Bone marrow panel validation

Validation of our TokuKit bone marrow specimen collection kit.

Next
Q3 2026

Platform

Auditable unsupervised clustering

Unsupervised clustering that meets CLIA-grade coefficients of variation. Results are human-interpretable and auditable, not a black box — so clinical trial teams can trust and defend them.

Later
Q4 2026

Platform

Programmable panels tool

Configure and compare custom panel builds without cytometry expertise.

Later
Q4 2026

Datasets

TokuKit performance across disease indications

Specimen stability and immune data comparisons across tumor indications. Downloadable for clinical trial planning.

Later
Q4 2026